COMMUNIQUÉS West-GlobeNewswire

Valneva annonce la mise à disposition de la documentation relative à son Assemblée Générale annuelle
04/06/2026
Lyon (France), le 4 juin 2026 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins (« la Société »), a annoncé aujourd’hui la mise à disposition de la documentation relative à son [...]
Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
04/06/2026
If approved, Joenja will be the first approved treatment in the U.S. for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Supplemental New Drug Application [...]
Jade Biosciences Announces Pricing of Public Offering of Common Stock
04/06/2026
SAN FRANCISCO and VANCOUVER, British Columbia, June 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in- [...]
Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032
04/06/2026
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of [...]
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
04/06/2026
LOUISVILLE, Ky., June 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex [...]
POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding
04/06/2026
Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1 Clinical Trials in the U.S. Buffalo, NY, June 03, 2026 (GLOBE NEWSWIRE) -- POP Biotechnologies, Inc. (“POP BIO”), a Buffalo-based biotechnology [...]
ACTG Launches HIV Cure Study Evaluating Novel Approach Targeting the HIV Reservoir
04/06/2026
CHAPEL HILL, N.C., June 03, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the recent opening of study A5413, a study that expands upon the [...]
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
04/06/2026
Reinforces Seer’s Clear Strategy, Strong Governance and Significant Long-Term Value Creation Opportunity Illustrates Why Radoff and Torok’s Short-Term Campaign Risks Disrupting Seer’s Momentum and Undermines Stockholder [...]
GLP North Adds Retaject Availability to Its Canadian Research Catalogue
03/06/2026
TORONTO, June 04, 2026 (GLOBE NEWSWIRE) -- GLP North, a Canadian supplier focused on ready-to-use research pen formats, has added Retaject availability to its Canadian research catalogue. The listing expands the company [...]
Booking Health Announces Release of Findings on International Access to Personalized Glioblastoma Treatment in Germany
03/06/2026
Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. [...]
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026
03/06/2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE [...]
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mai 2026
03/06/2026
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mai 2026 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE [...]
MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting
03/06/2026
NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today [...]
Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference
03/06/2026
NOVATO, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra [...]
Monthly information on share capital and company voting rights
03/06/2026
PARIS, June 03, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the capital Total number of voting rights 05/31/2026 100,691,658 106,134,467 For further [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
03/06/2026
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 03 juin 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
DBV Technologies Announces the Results of its 2026 Combined General Meeting
03/06/2026
Châtillon, France, June 3, 2026 DBV Technologies Announces the Results of its 2026 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq [...]
DBV Technologies annonce les résultats de son Assemblée Générale Mixte du 3 juin 2026
03/06/2026
Châtillon, France, le 3 juin 2026 DBV Technologies annonce les résultats de son Assemblée Générale Mixte du 3 juin 2026 Toutes les résolutions proposées à l’Assemblée Générale ont été adoptées DBV Technologies (Euronext [...]
Main Results of 2026 Annual and Extraordinary General Meeting
03/06/2026
The 2026 Annual and Extraordinary General Meeting of Alvotech (the "2026 AGM") was held on June 3, 2026, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg. All of the draft resolutions on the 2026 AGM [...]

Pages